{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-253795","form_type":"8-K","ticker":"AVA","cik":"0000104918","company_name":"AVISTA CORP","filed_at":"2026-06-02T21:02:55+00:00","discovered_at":"2026-06-02T21:04:00.247661+00:00","generated_at":"2026-06-02T21:04:22.295878+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"medium","headline":"Avista signs non-binding MOU for 125 MW load, expandable to 500 MW by 2032","bullets":["MOU with a developer in Avista's Washington service territory for initial 125 MW load starting 2029.","Pathway to expand to 500 MW by 2032, subject to further evaluation and regulatory review.","Next step is negotiation of an Engineering and Procurement Contract with financial assurances.","Project requires federal, state, and local permits, plus a filed Energy Services Agreement approved by WUTC.","Structure designed to provide net benefits to existing customers while supporting regional economic development."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-253795","json":"https://secwatch.observer/filing/0001193125-26-253795.json","markdown":"https://secwatch.observer/filing/0001193125-26-253795.md","text":"https://secwatch.observer/filing/0001193125-26-253795.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/104918/000119312526253795/0001193125-26-253795-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/104918/000119312526253795/ava-20260529.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T21:04:22.295878+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001437749-26-019196","ticker":"NRXP","company_name":"NRX Pharmaceuticals, Inc.","filed_at":"2026-06-02T21:30:08+00:00","headline":"NRx Pharmaceuticals proposes public offering of common stock; terms not set","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-019196","json":"https://secwatch.observer/filing/0001437749-26-019196.json","markdown":"https://secwatch.observer/filing/0001437749-26-019196.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1719406/000143774926019196/0001437749-26-019196-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1719406/000143774926019196/nrxp20260602_8k.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-064277","ticker":"TOPP","company_name":"Toppoint Holdings Inc.","filed_at":"2026-06-02T21:10:16+00:00","headline":"Topppoint issues statement at NYSE request; no undisclosed material developments behind unusual trading","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.35,"calibrated_materiality_score":0.35,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-064277","json":"https://secwatch.observer/filing/0001213900-26-064277.json","markdown":"https://secwatch.observer/filing/0001213900-26-064277.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1960847/000121390026064277/0001213900-26-064277-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1960847/000121390026064277/ea0293039-8k_toppoint.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-026875","ticker":"SQFT","company_name":"Presidio Property Trust, Inc.","filed_at":"2026-06-02T20:15:26+00:00","headline":"Presidio Property Trust annual meeting re-elects directors, approves incentive plan amendment; board reduced to five","event_type":"other_material","sec_items":["5.07","8.01","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026875","json":"https://secwatch.observer/filing/0001493152-26-026875.json","markdown":"https://secwatch.observer/filing/0001493152-26-026875.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1080657/000149315226026875/0001493152-26-026875-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1080657/000149315226026875/form8-k.htm"},"side_by_side_evidence":null},{"accession":"0001474098-26-000046","ticker":"PEB","company_name":"Pebblebrook Hotel Trust","filed_at":"2026-06-02T20:15:22+00:00","headline":"Pebblebrook Hotel Trust: Trustee Jackson retires; shareholders approve removal of trustee without cause","event_type":"other_material","sec_items":["5.02","5.07","8.01","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001474098-26-000046","json":"https://secwatch.observer/filing/0001474098-26-000046.json","markdown":"https://secwatch.observer/filing/0001474098-26-000046.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1474098/000147409826000046/0001474098-26-000046-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1474098/000147409826000046/peb-20260529.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-253506","ticker":"JAGX","company_name":"Jaguar Health, Inc.","filed_at":"2026-06-02T20:10:13+00:00","headline":"Jaguar Health issues 64,668 common shares for Series Q Preferred; annual meeting adjourned to June 8","event_type":"other_material","sec_items":["1.01","3.02","8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-253506","json":"https://secwatch.observer/filing/0001193125-26-253506.json","markdown":"https://secwatch.observer/filing/0001193125-26-253506.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526253506/0001193125-26-253506-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1585608/000119312526253506/d95782d8k.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-026866","ticker":"OTAI","company_name":"Starlink AI Acquisition Corp","filed_at":"2026-06-02T20:05:25+00:00","headline":"Starlink AI Acquisition closes partial over-allotment, adds $5M to trust","event_type":"other_material","sec_items":["3.02","8.01","9.01"],"materiality_score":0.4,"calibrated_materiality_score":0.4,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026866","json":"https://secwatch.observer/filing/0001493152-26-026866.json","markdown":"https://secwatch.observer/filing/0001493152-26-026866.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/2094076/000149315226026866/0001493152-26-026866-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2094076/000149315226026866/form8-k.htm"},"side_by_side_evidence":null},{"accession":"0000089439-26-000025","ticker":"MLI","company_name":"MUELLER INDUSTRIES INC","filed_at":"2026-06-02T14:47:05+00:00","headline":"Mueller Industries announces 2-for-1 stock split; record date June 25, 2026","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0000089439-26-000025","json":"https://secwatch.observer/filing/0000089439-26-000025.json","markdown":"https://secwatch.observer/filing/0000089439-26-000025.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/89439/000008943926000025/0000089439-26-000025-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/89439/000008943926000025/mli-20260602.htm"},"side_by_side_evidence":null},{"accession":"0001104659-26-069251","ticker":"SLS","company_name":"SELLAS Life Sciences Group, Inc.","filed_at":"2026-06-02T12:30:40+00:00","headline":"SELLAS Life Sciences raised $28.7M from warrant exercises in Apr-May 2026","event_type":"other_material","sec_items":["8.01","9.01"],"materiality_score":0.5,"calibrated_materiality_score":0.5,"match_reasons":["same SEC item: 8.01, 9.01","same event type: other_material","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-069251","json":"https://secwatch.observer/filing/0001104659-26-069251.json","markdown":"https://secwatch.observer/filing/0001104659-26-069251.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1390478/000110465926069251/0001104659-26-069251-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1390478/000110465926069251/tm2616601d1_8k.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}